allergic respiratory diseases
Conditions
Interventions
None listed
Sponsors
National Hospital Organization Sagamihara National Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: #Patients Adults and children, males and females, with IgE-mediated pollen, house dust mites, animal dander, and moulds respiratory allergy who will initiate aeroallergen AIT, either SCIT, SLIT-drops, or SLIT-tablets according to real life clinical standards of practice #Prescribers Doctors who are currently prescribing AIT as part of their regular clinical practice
Exclusion criteria
Exclusion criteria: (i) Patients and physicians who refused to participate in the study (ii) AIT for food (iii) AIT for toxic substances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical criteria used by treating clinicians and by the patients themselves, when establishing AIT as treatment in a patient with respiratory disease caused by an IgE-dependent hypersensitivity to aeroallergens. These are called "drivers of prescription". Among the different criteria selected by participants, the order of priority of AIT drivers will be established. | — |
Secondary
| Measure | Time frame |
|---|---|
| For sublingual immunotherapy, symptoms at initial induction. | — |
Countries
Japan
Contacts
Public ContactNaoko Fusayasu
National Hospital Organization Sagamihara National Hospital Clinical Research Center for Allergy and Rheumatology
Outcome results
None listed